Navigation Links
CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
Date:9/19/2007

n multiple fronts.

Multikine is also the first immunotherapeutic agent being developed as a first-line standard of care treatment for cancer. It is administered prior to any other cancer therapy because that is the period when the anti-tumor immune response can still be fully activated. Once the patient has advanced disease, or had surgery or has received radiation and/or chemotherapy, the immune system is severely weakened and is less able to mount an effective anti-tumor immune response. Other immunotherapies are administered after the patient has received chemotherapy and/or radiation therapy, which can limit their effectiveness.

The Company has operations in Vienna, Virginia and Baltimore, Maryland. CEL-SCI's other products, which are currently in pre-clinical stage, have shown protection against a number of diseases in animal tests and are being tested against diseases associated with bio-defense and avian flu.


'/>"/>
SOURCE CEL-SCI Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
2. CEL-SCI Presents Long-Term Cancer Survival Data With Multikine
3. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
6. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
7. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
8. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
9. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
10. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
11. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... -- The report "Silage Inoculants & Enzymes ... & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type & Geography ... & Enzymes Market is expected to reach $489.05 Million ... to 2020. Browse 75 market Tables ... P ages and an in-depth TOC on ...
(Date:7/2/2015)... , 2. Juli 2015 BGI gab ... in Hongkong vom American College of Pathologists ... ist das erste klinische Next-Generation-Sequencing Labor, das ... CAP-Zertifkat erhält und somit die höchsten Standards ... bestehenden US FDA - 21 CFR Part ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
... Spectros Corporation announced today that 2011 year-to-date sales revenue ... This continues the third year in a row for ... Tissue Oximeter product line was launched in 2008. ... market is embracing the Spectros state-of-the-art broadband VLS tissue ...
... Humira defect lawyers filed a lawsuit against ... drug, Humira, caused a life-threatening disease, leukemia. ... skin condition, psoriasis.  After taking the drug for approximately ... body while on a family vacation," says drug ...
Cached Medicine Technology:Spectros Corporation Year-To-Date Oximeter Sales Revenue Up 51% in First Half of 2011 2Perdue Kidd & Vickery Files Lawsuit Against Abbott Laboratories for Inadequate Leukemia and Cancer Warning 2
(Date:7/3/2015)... ... July 03, 2015 , ... Brendon Burchard's new High ... of media attention. In an effort to spread the news, a comprehensive review ... days many people are feeling overwhelmed by stress and fatigue," reports Hendricks. "Many ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. ... been retained to lead a national president recruitment for Regional Care, ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
(Date:7/3/2015)... TX (PRWEB) , ... July 03, 2015 , ... Jennifer ... First Choice Emergency Room , the largest network of independent freestanding emergency rooms ... new facility medical director of our Sienna Plantation facility,” said Executive Medical Director of ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is currently running a promotion ... of celebrities will have the opportunity to get 10% discount on orders that are ... do not have to use coupon codes or remember redemption codes. , There ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... Donna Edwards (D-Md.) for her introduction of the Stop Overdose Stat (S.O.S.) Act ... by Senator Jack Reed (D-R.I.), this Act seeks to decrease drug overdose – ...
Breaking Medicine News(10 mins):Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3
... Spanish . Barcelona, Spain: The largest study ... and survival after breast cancer has found that women from ... partly explained by more advanced cancer at diagnosis. Although ... with women consulting their doctors at a later stage when ...
... available in Spanish . Barcelona, Spain: ... surviving breast cancer and delaying childbirth, it is important to ... consideration when deciding on treatment, the seventh European Breast Cancer ... Armstrong, from the Department of Medical Oncology, the Christie NHS ...
... pregnant women in Bergen and Oslo will be invited ... The aim is to find out how influenza in ... also study any implications of vaccination during pregnancy. ... of swine influenza spread in Norway. Many young people ...
... ... ... 24, 2010 -- LogMatrix, a provider of log & threat management (SIEM), automated ... leading publication of security-related products and technologies has named their SIEM products ...
... expert says screening is best way to prevent breast cancer ... for breast cancer does not appear to increase overall survival ... survival rates may instead be due to controlling risk factors ... not as good as we hoped years ago," said study ...
... ... Australian start-up, has been selected to showcase its revolutionary service for managing and paying ... ... innovation conference, Finovate, has selected Controlabill to showcase its revolutionary service for managing and ...
Cached Medicine News:Health News:Worse breast cancer outcomes for women from poorer backgrounds are not due to late diagnosis alone 2Health News:Worse breast cancer outcomes for women from poorer backgrounds are not due to late diagnosis alone 3Health News:Fertility issues in young women with breast cancer must be addressed 2Health News:Influenza in pregnancy -- new Norwegian study 2Health News:LogMatrix Wins Info Security Products Guide “2010 Global Product Excellence Customer Trust Award” 2Health News:LogMatrix Wins Info Security Products Guide “2010 Global Product Excellence Customer Trust Award” 3Health News:Mammograms May Not Boost Survival, Danish Study Suggests 2Health News:Mammograms May Not Boost Survival, Danish Study Suggests 3Health News:Global Financial Innovations Conference Chooses Australian Start Up, Controlabill 2
... designed with Shallow Point Comfort Optimization for ... with its shallow-angled edges act like blades ... tearing the skin. The unique plastic used ... even for patients with arthritis or weak ...
... tenderfoot infant heelstick device uses a highly sharpened ... a gentle arc. The incision produced is carefully ... where most nerve fibers are located, but through ... high quality blood sample with significantly less pain ...
... To sample blood safely, simply and ... safety lancets comprises five versions, offering a ... to meet all your sampling requirements. ,All ... avoid needlestick injuries and prevent cross-infection, and ...
The Stat-Let lines of disposable lancets are all designed with the goals of providing a safe and easy to achieve capillary blood sampling. All of our lancets can be used by most current models of lan...
Medicine Products: